Testing patient skin cells to check gene-related disease causes
Part of Genetic & congenital clinical trials.
This trial builds lab tests using a patient’s own skin cells to see whether the disease’s underlying gene problem can be shown in the lab. If you have a rare inherited (genetic) disease with no good treatment, this could help researchers find clearer, functional ways to measure the disease and test future therapies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a rare genetic disorder (an orphan monogenic disease) with no satisfactory treatment option currently.
- Your doctor can identify a clear, specific gene/pathway cause for your condition.
- The researchers believe APTEEUS lab methods can show the functional cause using skin cells or cells made from them.
- You are able and allowed to have a skin biopsy (a small skin sample) if needed.
- You do not have an unclear or unidentified molecular cause for your disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects a small skin sample (biopsy) from people with ALS, those who carry an ALS gene mutation but have no symptoms, and healthy volunteers. The sample is used to grow cells in the lab to better understand how ALS develops.
This study looks at how to create laboratory models of genetic diseases using stem cells made from people’s cells. It may help researchers understand disease causes and how treatments could work, using genetic patients (and some non-patient controls).
This study collects skin cells from people with certain long-term conditions (or specific genetic disorders). Researchers use the cells to try to build new treatments for human disease and disability in the future.
This Phase 1 study looks at genetic risk factors in children with unusual skin lesions. The goal is to help doctors better decide which spots should be closely watched or safely biopsied.
This study is trying to find the gene or body-process cause of rare diseases (or rare forms of common diseases) when the reason is not yet understood. If you qualify, you may be asked to give genetic and health information that could help doctors diagnose and understand the condition better.
This study uses RNA sequencing to find genetic causes of rare diseases that standard DNA tests might miss. It may help people who have symptoms of a rare disease but no clear genetic diagnosis yet.
Hear when a new Monogenic Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.